Research and News Involving:
Rare Disease
Adult, Clinical Trials, Current Research, Drug, Pediatric, Rare Disease
Press Release: Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate...
Adult, Clinical Trials, Developing World, Dr. Hamaluba, Drug, Infectious Disease, KEMRI-Wellcome Trust Research Programme, LMICs, Minority/Underrepresented, Muhimbili University Health and Allied Sciences, Neglected Tropical Diseases, Oncology, Rare Disease, Women's Health
Press Release: Cures Within Reach and Open Philanthropy Expand Partnership to Address Factors that Lead to High Disease Burden in Low / Lower-Middle Income Countries Cures Within Reach and Open Philanthropy Expand Partnership to Address Factors that Lead to High...
Adult, Baylor College of Medicine, Brown University, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Shur, Drug, Health Disparities, Minority/Underrepresented, Neuro, Oncology, Pediatric, Rare Disease, University of California San Francisco
Press Release: Finalists Announced for CureAccelerator Live! for Diversity, Equity & Inclusion Competition Finalists Announced for CureAccelerator Live! for Diversity, Equity & Inclusion Competition Cures Within Reach’s Virtual Pitch Event on October 6...
Adult, Busitema University, Clinical Trials, Developing World, Dr. Adewole, Dr. Johnson, Dr. Malichewe, Dr. Musaba, Dr. Namazzi, Drug, Global Health Uganda, Infectious Disease, LMICs, Minority/Underrepresented, Muhimbili University Health and Allied Sciences, Neglected Tropical Diseases, Obafemi Awolowo University & Teaching Hospitals Complex, Oncology, Rare Disease, Université d'Abomey-Calavi, Women's Health
Press Release: Four clinical trials impacting high disease burden in LMICs will start soon Four clinical trials impacting high disease burden in LMICs will start soon Cures Within Reach also announces its latest success story and a multi-year grant from Open...
Adult, Brown University, Chicago, Children's National Research Institute, Clinical Trials, Developing World, Dr. Amorim, Dr. Holder, Dr. Ibraheem, Dr. Linnstaedt, Dr. Mondal, Dr. Musaba, Dr. Shur, Dr. Wesevich, Dr. Zimba, Drug, Health Disparities, International Centre for Diarrhoeal Disease Research Bangladesh, LMICs, Minority/Underrepresented, Neglected Tropical Diseases, Neuro, Oncology, Pediatric, Rare Disease, ReGRoW, University of California San Francisco, University of Chicago, University of Illinois at Chicago, University of North Carolina Chapel HIll, University of Zambia School of Medicine, Women's Health
Press Release: Eight clinical trials starting soon in health disparities and/or led by underserved researchers Eight clinical trials starting soon in health disparities and/or led by underserved researchers These Diversity, Equity & Inclusion trials funded by...
Patient Impact Awards, Penn Medicine, Rare Disease
Press Release: Cures Within Reach Names its 2022 Patient Impact Award Recipients Cures Within Reach Names its 2022 Patient Impact Award Recipients David C. Fajgenbaum, MD, MBA, MSc of Penn Medicine / CDRC and Incyte to be honored in 2022 June 2, 2022 Cures Within...
Adult, Chicago, Cincinnati Children's Hospital Medical Center, Clinical Trials, Developing World, Device, Drug, Emory University, Health Disparities, LMICs, Minority/Underrepresented, Neuro, Oncology, Pediatric, Rare Disease, Stanford University, University of California Los Angeles, University of Illinois at Chicago, Women's Health
Press Release: Nine clinical trials starting soon in health disparities and/or led by underserved researchers Nine clinical trials starting soon in health disparities and/or led by underserved researchers These Diversity, Equity & Inclusion trials, funded by Cures...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Virtual Pitch Event on June 11 Features 5 Clinical Repurposing Projects April 21, 2020...
Adult, Clinical Trials, Dr. Nichols, Drug, Oncology, Pediatric, Rare Disease, St. Jude Children's Research Hospital
Press Release: St. Jude Researcher Wins CureAccelerator Live! for Rare Diseases St. Jude Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial for Ultrarare Hemophagocytic Lymphohistiocytosis Receives Funding to Repurpose Existing Blood Cancer...
Adult, Clinical Trials, Dr. Nichols, Drug, Oncology, Pediatric, Rare Disease, St. Jude Children's Research Hospital
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases Competition Finalists Announced for CureAccelerator Live! for Rare Diseases Competition Pitch Event on June 6 in Philadelphia Features 4 Clinical Repurposing Projects April 3, 2019 Cures...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial in Myeloproliferative Neoplasms Receives Funding to...
Adult, Brigham Young University, Clinical Trials, Dr. Ghosh, Dr. Ito, Dr. Ohanian, Dr. Romancik, Dr. Watt, Drug, Emory University, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center, University of Michigan, University of Pittsburgh
Press Release: Five clinical trials impacting blood cancers approved for funding Five clinical trials impacting blood cancers approved for funding Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors...
Adult, Baylor College of Medicine, Brown University, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Shur, Drug, Health Disparities, Minority/Underrepresented, Neuro, Oncology, Pediatric, Rare Disease, University of California San Francisco
Press Release: Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Clinical Repurposing Trials in Bladder Cancer...
Adult, Cincinnati Children's Hospital Medical Center, Clinical Trials, Developing World, Device, Drug, Emory University, Health Disparities, Minority/Underrepresented, Neuro, Oncology, Rare Disease, SIDS Hospital and Research Centre, Stanford University, University College Hospital Ibadan, University of California Los Angeles, University of Illinois at Chicago
Press Release: Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers Ten clinical trials starting soon in Diversity, Equity...
Clinical Trials, Dr. Gordon, Dr. Rower, Dr. Teng, Minority/Underrepresented, Oncology, Pediatric, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, University of Utah
Press Release: Stanford and MD Anderson Researchers Both Win CureAccelerator Live! for Pediatric Rare Diseases Stanford and MD Anderson Researchers Both Win CureAccelerator Live! for Pediatric Rare Diseases Clinical Repurposing Trials in Vascular Malformations and...
Adult, Clinical Trials, DEBRA Chile, Dr. Gordon, Dr. Rower, Dr. Teng, Drug, Minority/Underrepresented, Oncology, Pediatric, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, University of Utah
Press Release: Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Virtual Pitch Event on June 10 Features 4 Pediatric...
Adult, Chicago, Clinical Trials, Dr. Liotta, Dr. Meltzer, Dr. Rado, Drug, Edward Hines Jr. VA Hospital and CARES, Health Disparities, Infectious Disease, Loyola University Medical Center, Military/Veteran, Neuro, Northwestern University, Oncology, Rare Disease, Shirley Ryan AbilityLab, University of Chicago, Women's Health
Press Release: Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago Trials at the University of Chicago, Northwestern University and Shirley Ryan AbilityLab...
Adult, Chicago, Clinical Trials, Dr. Liotta, Edward Hines Jr. VA Hospital and CARES, Loyola University Medical Center, Military/Veteran, Neuro, Northwestern University, Oncology, Rare Disease, Shirley Ryan AbilityLab, Women's Health
Press Release: Finalists Announced for CureAccelerator Live! for Chicago 2020 Competition Finalists Announced for CureAccelerator Live! for Chicago 2020 Competition Virtual Pitch Event on September 15 Features 4 Clinical Repurposing Projects from Chicago Region July...
Adult, Chicago, Current Research, Device, Dr. Kletzel, Edward Hines Jr. VA Hospital and CARES, Military/Veteran, Neuro, Rare Disease
Improving Cognitive Function in Veterans with Atypical Parkinsonism with rTMS Brain Stimulation Principal Investigator: Dr. Sandra Kletzel Disease: Atypical Parkinsonism Research Description: Atypical parkinsonisms (APs) represent a group of progressive nervous system...
Adult, Current Research, Developing World, Dr. Malichewe, Drug, LMICs, Minority/Underrepresented, Muhimbili University Health and Allied Sciences, Oncology, Rare Disease, ReGRoW
Testing a Generic Drug Combination to Treat AML in Tanzania Principal Investigator: Dr. Christina Malichewe Disease: Acute Myeloid Leukemia Research Description: Acute myeloid leukemia (AML) is a blood cancer that is difficult to manage, and patients may have shorter...
